Basic Info
  • Factory Location: Lianyungang

    Main Sales Markets: Central/South America

  • Sample Provided: no

    China GMP

    Form: DPI

    Strength: 18mcg

    Indication: indicated for the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is indicated to reduce exacerbations in COPD patients

Send your message to this supplier
  • From:
  • To:
    Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service